STREAM clinical trial results provide vital insight into nine-month treatment regimen for multidrug-resistant tuberculosis (PDF 87 KB)

Preliminary results from Stage 1 of the STREAM randomised clinical trial show that the nine-month treatment regimen being tested achieved favourable outcomes in almost 80 percent of those treated.

Wirelessly Observed Therapy could revolutionise tuberculosis treatment, researchers to tell the 48th Union World Conference on Lung Health in Guadalajara, Mexico, 11-14 October, 2017 (PDF 60 KB)

A range of new technological advances in the diagnosis and treatment of tuberculosis to be unveiled for the first time in Guadalajara.

The Union welcomes the WHO's recognition of TB alongside other pathogens as priority for R&D

The Union welcomes the WHO’s Priority Pathogen Report, released today, highlighting drug-resistant tuberculosis (DR-TB) as a priority for research and development in the battle against AMR.

Breakthrough research linking diabetes and TB infection to be announced at the 48th Union World Conference on Lung Health in Guadalajara (PDF 153 KB)

Conference to be opened by the Mexican Secretary of Health, Dr José Narro Robles and feature address by H.E. Dr Tabaré Ramón Vázquez Rosas, President of Uruguay

The Union welcomes major finance firms’ pledge of public support for tobacco control

On World No Tobacco Day, The Union welcomes the announcement from 53 leading finance firms that today affirmed their public support for international efforts to reduce tobacco use under the WHO FCTC.

Forum of International Respiratory Societies (FIRS) issues five key points, critical to addressing tuberculosis epidemic (PDF 125 KB)

In support of World TB Day, 24 March, the Forum of International Respiratory Societies (FIRS) urges action on five united strategies to ensure the aim of ending tuberculosis (TB) by 2030 becomes achievable, despite new and emerging challenges.

The 48th Union World Conference on Lung Health in Guadalajara, Mexico launched ahead of World TB Day (PDF 93 KB)

Mexican footballer Andrés Guardado announced as Conference Ambassador - The 48th Union World Conference on Lung Health, to be held at the Expo Guadalajara Convention Centre in Guadalajara, Mexico, on 11-14 October this year

Statement from The International Union Against Tuberculosis and Lung Disease (The Union) on Bedaquiline access, India (PDF 281 KB)

Drug-resistant TB is one of the most terrible diseases that any person can ever face. The health system must do everything in its power to provide access to effective treatments for every patient.

World Health Organization Framework Convention on Tobacco Control, 7th Conference of the Parties Begins in New Delhi, India (PDF 236KB)

Tobacco use is still the greatest preventable cause of death worldwide. It claims more than six million lives each year. In total it is projected to kill up to one billion people this century unless there is a coordinated and sustained intervention.

An innovative new tool to assess the sustainability of national tobacco control programmes launched by The Union

The Index of Tobacco Control Sustainability (ITCS) has been launched by the International Union Against Tuberculosis and Lung Disease (The Union) to assist countries to assess and guide national tobacco control programmes to become sustainable.

Natural Disasters and Weak Health Systems Force Innovative Approaches to Delivering Tuberculosis Treatment and Care: Studies

New research announced today demonstrates the innovation needed to maintain tuberculosis (TB) treatment and care in the face of natural disasters and weak health systems.

New Links Found Between Tuberculosis and Non-communicable Diseases

A series of new research announced today demonstrates linkages between tuberculosis (TB), an infectious disease, and non-communicable diseases including chronic kidney disease and diabetes.

Research Finds Promise in Shorter, More Effective Approaches to Treating Drug-Resistant Tuberculosis (PDF 346 KB)

With improper treatment, drug-resistance can develop quickly. Health clinics are missing opportunities to diagnose drug-resistant TB sooner, studies show. New research was presented at the 47th Union World Conference on Lung Health.

Breakthrough study demonstrates far shorter, more effective treatment for multidrug-resistant tuberculosis (MDR-TB), with majority cured (PDF 334KB)

Final results demonstrated nine-month treatment had 82% success rate, compared with previous standard that required more than 20 months of treatment and achieved cure rates below 55%

47th Union World Conference on Lung Health Announces “Community Common” Programme Highlights (PDF 97KB)

Highlights include Mini-Football Tournament and Live Open Fire Display of New Clean Cook-stove Technology That Can Reduce Deadly Childhood Pneumonia